Company Overview
Snapshot
Founded in January 2008 by Idan Tobis, Tavor operates with 1–10 employees. The company focuses on developing innovative solutions for anterior cruciate ligament (ACL) reconstruction surgery. In December 2014, Tavor's inventors were recognized with Untold News Awards for their innovative approach.
Business overview
Tavor develops medical devices for anterior cruciate ligament (ACL) reconstruction surgery, operating within the Health Tech & Life Sciences sector. Its core product, Knee-T-Nol, is an artificial implant designed as a safe and effective off-the-shelf alternative to traditional autografts or allografts. This ligament prosthesis, made from braided, super-elastic nitinol strands, provides mechanical strength while allowing for natural flexion and torsion, serving the orthopedics and surgical instruments markets.
Strategic signal
In December 2014, Tavor's inventors received Untold News Awards for their innovative solutions. This recognition highlights the company's commitment to developing novel medical technologies and signals to investors a validation of its inventive capabilities within the medical device industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Tavor's primary product?
- Tavor's primary product is Knee-T-Nol, an artificial implant designed for anterior cruciate ligament (ACL) reconstruction surgery. It is a ligament prosthesis made from braided, super-elastic nitinol strands.
- When was Tavor founded?
- Tavor was founded in January 2008.
- Who is the founder of Tavor?
- Idan Tobis is the founder and chairman of Tavor.
- What recognition did Tavor's inventors receive?
- In December 2014, Tavor's inventors won Untold News Awards for their innovative contributions.
- What problem does Knee-T-Nol address?
- Knee-T-Nol provides a durable and effective solution for ACL reconstruction surgery, offering an artificial implant alternative to autografts or allografts.